Prevalence of Brain Health Versus Neurodegeneration in Former Professional Football Players

Status: Recruiting
Location: See location...
Intervention Type: Drug, Diagnostic test
Study Type: Observational
SUMMARY

This project will define the prevalence of brain health (i.e., normal cognitive, neuromotor, behavioral function) in living professional football retirees and group-matched controls through a comprehensive assessment of clinical, neuroimaging, and biomarker measures.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 29
Maximum Age: 59
Healthy Volunteers: t
View:

⁃ Former professional football player/exposed group:

• Professional football retiree aged 29-59

• Played a minimum of 3 professional football seasons, with a minimum of 3 games in each season

• Fluent in English (translations are not available/validated for most neuropsychological tests)

⁃ Control/unexposed group:

• Age 29-59 male

• High school education or beyond

• Fluent in English (translations are not available/validated for most neuropsychological tests)

Locations
United States
Pennsylvania
University of Pittsburgh Department of Neurosurgery
RECRUITING
Pittsburgh
Contact Information
Primary
Kathryn L Edelman, MS
dunfeekl@upmc.edu
412-624-1077
Time Frame
Start Date: 2019-11-18
Estimated Completion Date: 2025-12
Participants
Target number of participants: 300
Treatments
Former Professional Football Players
Former professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Control Groups
Friends and brothers of the Former Professional Football Player group.
Related Therapeutic Areas
Sponsors
Collaborators: Avid Radiopharmaceuticals, Inc., National Football League Scientific Advisory Board, Harvard University
Leads: David Okonkwo, MD, PhD

This content was sourced from clinicaltrials.gov